Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.1 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.70.
Market Cap
9.1T
Revenue
4.59T
Profits
199.17B
PE Ratio
45.70
Profit Margin
4.34%
Dividend Yield
0.39%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | 1.42% | 1,433,969 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 628.86B | 2.86% | 3,252,781 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 458.02B | 3.26% | 2,327,095 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 384.01B | -0.87% | 2,042,974 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 316.56B | 2.23% | 3,026,417 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 285.33B | 5.18% | 1,748,260 | 60.44B |
| 7 | NVS | Novartis AG | 283.14B | 2.89% | 1,086,317 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 225.09B | 2.63% | 8,143,007 | 50.57B |
| 9 | AMGN | Amgen Inc. | 200.08B | 2.60% | 826,756 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 193.37B | 1.36% | 1,062,082 | 45.20B |
| 11 | ABT | Abbott Laboratories | 165.28B | 2.94% | 6,282,224 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 161.14B | 3.03% | 3,072,136 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 149.39B | 4.83% | 1,599,734 | 10.58B |
| 14 | DHR | Danaher Corporation | 139.11B | 1.46% | 1,852,211 | 24.78B |
| 15 | PFE | Pfizer Inc. | 138.30B | 1.61% | 25,394,132 | 63.32B |
| 16 | CVS | CVS Health Corporation | 132.21B | -1.14% | 3,047,799 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 131.75B | 4.24% | 774,048 | 12.22B |
| 18 | SYK | Stryker Corporation | 124.50B | 3.63% | 1,668,542 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 116.63B | 1.20% | 3,187,132 | 48.48B |
| 20 | GSK | GSK plc | 106.71B | 3.74% | 2,369,162 | 43.29B |
| 21 | MDT | Medtronic plc | 105.57B | 4.13% | 4,290,485 | 36.36B |
| 22 | SNY | Sanofi | 99.86B | 3.00% | 2,098,475 | 54.60B |
| 23 | MCK | McKesson Corporation | 91.90B | 2.20% | 344,330 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 91.56B | 4.96% | 922,084 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 90.23B | -0.17% | 730,960 | 200.42B |
| 26 | CI | The Cigna Group | 74.48B | 1.62% | 933,842 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 66.83B | 4.41% | 15,508,917 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 65.42B | 2.93% | 424,092 | 14.92B |
| 29 | COR | Cencora, Inc. | 57.08B | 1.72% | 402,179 | 328.68B |
| 30 | ARGX | argenx SE | 56.21B | 3.37% | 35,978 | 4.74B |
| 31 | MDLN | Medline Inc. | 56.16B | 2.44% | 4,386,623 | 29.14B |
| 32 | CAH | Cardinal Health, Inc. | 55.89B | 0.39% | 575,818 | 250.74B |
| 33 | EW | Edwards Lifesciences Corporation | 54.10B | 2.14% | 1,346,691 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 51.30B | 4.45% | 1,959,999 | 28.34B |
| 35 | HUM | Humana Inc. | 47.40B | -3.58% | 792,028 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.64B | 2.92% | 353,093 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 43.18B | 2.49% | 970,235 | 22.23B |
| 38 | HLN | Haleon plc | 42.46B | 3.88% | 5,700,880 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.51B | 3.05% | 514,669 | 4.29B |
| 40 | NTRA | Natera, Inc. | 39.44B | -0.32% | 766,449 | 2.50B |
| 41 | RVMD | Revolution Medicines, Inc. | 39.31B | -1.39% | 962,415 | - |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 39.21B | 0.69% | 2,523,586 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.18B | -1.32% | 506,774 | 7.23B |
| 44 | WAT | Waters Corporation | 36.72B | -1.10% | 296,929 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.44B | 1.56% | 458,246 | 16.63B |
| 46 | ALC | Alcon Inc. | 33.47B | 2.68% | 875,402 | 10.63B |
| 47 | CNC | Centene Corporation | 33.16B | -1.74% | 1,537,640 | 178.33B |
| 48 | ONC | BeOne Medicines AG | 32.71B | 1.20% | 13,791 | 5.70B |
| 49 | RPRX | Royalty Pharma plc | 32.60B | 1.49% | 1,446,859 | 2.44B |
| 50 | BIIB | Biogen Inc. | 31.61B | 2.09% | 517,495 | 9.94B |
| 51 | ZTS | Zoetis Inc. | 31.33B | 3.15% | 1,901,275 | 9.53B |
| 52 | VEEV | Veeva Systems Inc. | 31.05B | 3.77% | 1,159,147 | 3.32B |
| 53 | MRNA | Moderna, Inc. | 30.97B | 7.66% | 9,778,119 | 2.23B |
| 54 | RMD | ResMed Inc. | 30.05B | 3.45% | 447,339 | 5.54B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 29.56B | 0.20% | 1,775,332 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 28.45B | 2.25% | 1,865,139 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 27.47B | 3.37% | 1,343,843 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 26.39B | 1.43% | 58,261 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 26.22B | -0.20% | 81,838 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.68B | -0.41% | 221,206 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.97B | -0.88% | 1,983,015 | 8.26M |
| 62 | BNTX | BioNTech SE | 24.44B | 2.92% | 969,933 | 3.23B |
| 63 | DGX | Quest Diagnostics Incorporated | 23.83B | -0.33% | 286,272 | 11.28B |
| 64 | INSM | Insmed Incorporated | 23.69B | 2.13% | 1,283,899 | 819.56M |
| 65 | UTHR | United Therapeutics Corporation | 23.59B | 1.57% | 225,080 | 3.17B |
| 66 | LH | Labcorp Holdings Inc. | 23.29B | 0.05% | 209,271 | 14.14B |
| 67 | INCY | Incyte Corporation | 22.95B | 0.95% | 1,428,003 | 5.36B |
| 68 | GH | Guardant Health, Inc. | 22.37B | -1.22% | 2,092,540 | 1.08B |
| 69 | STE | STERIS plc | 21.17B | 2.31% | 192,510 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.11B | 1.42% | 3,614,693 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 17.87B | 8.52% | 1,158,638 | 21.46B |
| 72 | GMAB | Genmab A/S | 17.61B | 2.32% | 934,071 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.28B | 2.41% | 442,851 | 3.10B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 16.77B | 2.98% | 750,728 | 8.41B |
| 75 | ASND | Ascendis Pharma A/S | 16.68B | 0.29% | 252,698 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 15.94B | 2.68% | 198,776 | 2.68B |
| 77 | DVA | DaVita Inc. | 15.09B | 3.10% | 367,061 | 13.84B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 14.97B | 0.49% | 203,668 | 4.44B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.91B | 2.13% | 1,826,883 | 579.96M |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.37B | -1.27% | 1,221,915 | 13.65B |
| 81 | COO | The Cooper Companies, Inc. | 14.33B | 2.10% | 1,423,186 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.83B | 1.95% | 966,873 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.64B | 0.50% | 372,489 | 8.26B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.23B | 1.07% | 855,449 | 1.06B |
| 85 | ALGN | Align Technology, Inc. | 13.20B | 1.54% | 494,933 | 4.10B |
| 86 | ICLR | ICON Public Limited Company | 13.11B | -2.20% | 506,132 | 8.27B |
| 87 | FMS | Fresenius Medical Care AG | 12.65B | 2.67% | 980,711 | 22.32B |
| 88 | PEN | Penumbra, Inc. | 12.54B | 0.78% | 118,119 | 1.45B |
| 89 | RVTY | Revvity, Inc. | 12.54B | -0.40% | 308,021 | 2.90B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 12.45B | 0.53% | 334,765 | 708.24M |
| 91 | SNN | Smith & Nephew plc | 12.33B | 4.66% | 1,218,720 | 6.16B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.24B | 1.70% | 2,132,083 | 4.89B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | 1.97% | 16,908 | 1.13B |
| 94 | MOH | Molina Healthcare, Inc. | 11.88B | -1.90% | 308,109 | 43.10B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.79B | 2.11% | 1,074,848 | 3.58B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.75B | 1.50% | 747,219 | 105.82M |
| 97 | SMMT | Summit Therapeutics Inc. | 11.70B | 4.83% | 4,389,704 | - |
| 98 | BAX | Baxter International Inc. | 11.55B | 3.07% | 3,197,417 | 11.32B |
| 99 | PODD | Insulet Corporation | 11.50B | 3.91% | 713,962 | 2.90B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.44B | 1.01% | 779,359 | 622.01M |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.32B | 1.31% | 570,492 | 3.24B |
| 102 | TECH | Bio-Techne Corporation | 11.01B | -0.49% | 5,062,412 | 1.21B |
| 103 | CRL | Charles River Laboratories International, Inc. | 10.95B | -0.80% | 376,353 | 4.03B |
| 104 | KRYS | Krystal Biotech, Inc. | 10.89B | -0.60% | 93,457 | 417.30M |
| 105 | GMED | Globus Medical, Inc. | 10.79B | 4.69% | 646,432 | 3.10B |
| 106 | ABVX | ABIVAX Société Anonyme | 10.67B | 7.91% | 2,890,416 | 5.67M |
| 107 | TEM | Tempus AI, Inc. | 10.61B | -4.04% | 3,705,505 | 1.36B |
| 108 | EHC | Encompass Health Corporation | 10.53B | 4.67% | 434,847 | 6.07B |
| 109 | APGE | Apogee Therapeutics, Inc. | 9.95B | - | 1,685,556 | - |
| 110 | NUVL | Nuvalent, Inc. | 9.77B | 0.04% | 569,405 | - |
| 111 | ENSG | The Ensign Group, Inc. | 9.73B | 1.84% | 254,898 | 5.27B |
| 112 | HSIC | Henry Schein, Inc. | 9.72B | 0.97% | 1,080,758 | 13.38B |
| 113 | UHS | Universal Health Services, Inc. | 9.71B | 6.49% | 643,794 | 17.76B |
| 114 | OSCR | Oscar Health, Inc. | 9.60B | -0.13% | 4,204,449 | 13.30B |
| 115 | IBRX | ImmunityBio, Inc. | 9.53B | -1.09% | 9,331,434 | 140.98M |
| 116 | CORT | Corcept Therapeutics Incorporated | 9.48B | -0.19% | 360,854 | 769.10M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 9.28B | 1.61% | 626,010 | 1.51B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.26B | -1.44% | 410,909 | 51.48M |
| 119 | BRKR | Bruker Corporation | 9.15B | -0.85% | 2,368,067 | 3.46B |
| 120 | ALKS | Alkermes plc | 8.88B | 3.02% | 717,423 | 1.56B |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.79B | -1.31% | 194,072 | 7.46M |
| 122 | HIMS | Hims & Hers Health, Inc. | 8.45B | -2.79% | 11,061,118 | 2.37B |
| 123 | GKOS | Glaukos Corporation | 8.44B | 4.48% | 496,747 | 551.35M |
| 124 | PCVX | Vaxcyte, Inc. | 8.30B | 2.51% | 350,923 | - |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 8.25B | 2.54% | 273,915 | 74.06M |
| 126 | QGEN | Qiagen N.V. | 8.25B | 1.99% | 103,475 | 2.10B |
| 127 | ATR | AptarGroup, Inc. | 8.04B | 0.63% | 108,635 | 3.87B |
| 128 | RGEN | Repligen Corporation | 8.00B | 2.06% | 512,771 | 763.34M |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 7.99B | 0.49% | 57,165 | 2.59B |
| 130 | HQY | HealthEquity, Inc. | 7.89B | 2.31% | 427,907 | 1.34B |
| 131 | IMVT | Immunovant, Inc. | 7.80B | -0.45% | 346,021 | - |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.72B | 2.02% | 380,096 | 217.17M |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | 7.51B | 2.27% | 320,242 | 569.61M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.46B | -3.35% | 448,291 | - |
| 135 | TGTX | TG Therapeutics, Inc. | 7.33B | -3.34% | 1,514,407 | 700.35M |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.08B | -0.15% | 184,277 | 1.55B |
| 137 | PACS | PACS Group, Inc. | 7.07B | 0.79% | 562,919 | 5.43B |
| 138 | LQDA | Liquidia Corporation | 6.94B | -1.59% | 540,416 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 6.91B | 1.05% | 3,798,833 | 6.55B |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.80B | 0.78% | 563,976 | 827.11M |
| 141 | COGT | Cogent Biosciences, Inc. | 6.49B | -1.30% | 934,762 | - |
| 142 | CHE | Chemed Corporation | 6.48B | 1.94% | 80,561 | 2.54B |
| 143 | HNGE | Hinge Health, Inc. | 6.47B | -1.79% | 568,562 | 646.34M |
| 144 | SRRK | Scholar Rock Holding Corporation | 6.34B | 0.13% | 830,488 | - |
| 145 | GRFS | Grifols, S.A. | 6.27B | 0.56% | 1,114,105 | 8.58B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.20B | 0.36% | 215,293 | 274.48M |
| 147 | TWST | Twist Bioscience Corporation | 6.13B | -3.80% | 795,316 | 409.48M |
| 148 | CGON | CG Oncology, Inc. | 6.08B | -2.76% | 299,303 | 5.07M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.06B | 2.66% | 247,938 | 5.21B |
| 150 | TFX | Teleflex Incorporated | 5.87B | 2.17% | 236,699 | 2.13B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.82B | -0.15% | 837,965 | 7.50M |
| 152 | LEGN | Legend Biotech Corporation | 5.80B | 0.37% | 938,670 | 1.14B |
| 153 | DFTX | Definium Therapeutics, Inc. | 5.74B | -0.44% | 1,389,028 | - |
| 154 | CRSP | CRISPR Therapeutics AG | 5.69B | 6.09% | 2,055,380 | 4.10M |
| 155 | BLTE | Belite Bio, Inc | 5.67B | 1.33% | 7,495 | - |
| 156 | ERAS | Erasca, Inc. | 5.51B | -1.14% | 2,039,185 | - |
| 157 | BLLN | BillionToOne, Inc. | 5.49B | -2.49% | 267,334 | 354.54M |
| 158 | RDNT | RadNet, Inc. | 5.44B | 5.36% | 856,057 | 2.14B |
| 159 | AMRX | Amneal Pharmaceuticals, Inc. | 5.42B | 0.12% | 666,033 | 3.05B |
| 160 | CAI | Caris Life Sciences, Inc. | 5.18B | -2.35% | 1,502,526 | 907.29M |
| 161 | MANE | Veradermics, Incorporated | 5.15B | -4.03% | 251,254 | - |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.12B | -2.20% | 856,337 | 536.20M |
| 163 | STVN | Stevanato Group S.p.A. | 5.12B | 2.29% | 135,031 | 1.39B |
| 164 | CELC | Celcuity Inc. | 5.12B | 0.48% | 394,835 | - |
| 165 | SHC | Sotera Health Company | 5.04B | -0.34% | 994,087 | 1.19B |
| 166 | ORKA | Oruka Therapeutics, Inc. | 5.04B | -10.37% | 1,989,222 | - |
| 167 | DNTH | Dianthus Therapeutics, Inc. | 5.00B | 1.32% | 62,432 | 1.34M |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.92B | -0.96% | 1,427,370 | 4.26B |
| 169 | TXG | 10x Genomics, Inc. | 4.91B | -1.05% | 1,338,351 | 638.78M |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.87B | 0.76% | 237,347 | 754.05M |
| 171 | INDV | Indivior Pharmaceuticals, Inc. | 4.85B | -1.22% | 771,396 | 1.29B |
| 172 | VCYT | Veracyte, Inc. | 4.62B | -3.29% | 399,791 | 541.74M |
| 173 | LIVN | LivaNova PLC | 4.54B | 0.29% | 249,396 | 1.43B |
| 174 | WAY | Waystar Holding Corp. | 4.49B | 9.19% | 4,440,260 | 1.16B |
| 175 | NVST | Envista Holdings Corporation | 4.44B | 0.33% | 712,199 | 2.81B |
| 176 | MMED | MiniMed Group, Inc. | 4.38B | 2.63% | 152,591 | 3.10B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.37B | 1.19% | 648,305 | 1.10B |
| 178 | LFST | LifeStance Health Group, Inc. | 4.36B | -1.57% | 2,851,480 | 1.49B |
| 179 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.35B | 6.71% | 1,086,428 | 18.07M |
| 180 | VKTX | Viking Therapeutics, Inc. | 4.31B | -0.97% | 1,281,784 | - |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.22B | 1.76% | 263,661 | 1.54B |
| 182 | IRTC | iRhythm Holdings, Inc. | 4.17B | 1.99% | 38,271 | 787.85M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 4.17B | -0.96% | 456,226 | - |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.15B | -0.21% | 1,345,062 | 56.99M |
| 185 | CON | Concentra Group Holdings Parent, Inc. | 4.05B | 2.91% | 542,409 | 2.23B |
| 186 | DNLI | Denali Therapeutics Inc. | 4.04B | -1.91% | 614,720 | - |
| 187 | TLX | Telix Pharmaceuticals Limited | 4.04B | -0.63% | 34,055 | 803.79M |
| 188 | DOCS | Doximity, Inc. | 4.02B | 1.85% | 1,665,727 | 644.86M |
| 189 | NAMS | NewAmsterdam Pharma Company N.V. | 3.99B | -2.87% | 771,697 | 22.57M |
| 190 | RLAY | Relay Therapeutics, Inc. | 3.89B | 0.51% | 1,044,451 | 10.68M |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 840,370 | 596.96M |
| 192 | ICUI | ICU Medical, Inc. | 3.82B | 2.93% | 195,364 | 2.16B |
| 193 | BKD | Brookdale Senior Living Inc. | 3.77B | -0.25% | 920,040 | 3.00B |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.75B | 4.04% | 1,007,876 | - |
| 195 | GPCR | Structure Therapeutics Inc. | 3.73B | 0.71% | 345,134 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.71B | 2.07% | 631,215 | 236.00M |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.63B | 2.77% | 150,903 | - |
| 198 | WRBY | Warby Parker Inc. | 3.58B | -0.58% | 1,043,910 | 890.57M |
| 199 | OGN | Organon & Co. | 3.55B | - | 555,155 | 6.16B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.52B | 2.27% | 498,584 | 225.27M |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.47B | 2.01% | 437,827 | - |
| 202 | PRVA | Privia Health Group, Inc. | 3.45B | 1.97% | 375,893 | 2.25B |
| 203 | ADPT | Adaptive Biotechnologies Corporation | 3.43B | -4.16% | 2,094,084 | 295.41M |
| 204 | OPCH | Option Care Health, Inc. | 3.43B | 3.83% | 873,029 | 5.67B |
| 205 | NHC | National HealthCare Corporation | 3.40B | 2.20% | 46,621 | 1.53B |
| 206 | BEAM | Beam Therapeutics Inc. | 3.36B | 0.78% | 1,231,126 | 164.01M |
| 207 | HAE | Haemonetics Corporation | 3.35B | -1.44% | 504,080 | 1.33B |
| 208 | ALMS | Alumis Inc. | 3.30B | -2.93% | 826,352 | 8.40M |
| 209 | ITGR | Integer Holdings Corporation | 3.24B | 0.95% | 59,155 | 1.86B |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | -0.64% | 588,925 | 415.62M |
| 211 | RARE | Ultragenyx Pharmaceutical Inc. | 3.20B | 0.68% | 514,459 | 670.00M |
| 212 | RGC | Regencell Bioscience Holdings Limited | 3.19B | -19.80% | 740,147 | - |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 2.97B | 3.36% | 1,684,761 | 3.37B |
| 214 | GRAL | GRAIL, Inc. | 2.92B | 0.01% | 169,740 | 156.12M |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.92B | 1.25% | 283,309 | 865.00K |
| 216 | VERA | Vera Therapeutics, Inc. | 2.88B | -5.84% | 3,571,233 | - |
| 217 | IRON | Disc Medicine, Inc. | 2.88B | 0.63% | 341,550 | - |
| 218 | QURE | uniQure N.V. | 2.84B | -8.43% | 1,918,169 | 18.09M |
| 219 | KLRA | Kailera Therapeutics, Inc. | 2.79B | 3.36% | 173,431 | - |
| 220 | TARS | Tarsus Pharmaceuticals, Inc. | 2.78B | 6.01% | 504,770 | 535.08M |
| 221 | CLOV | Clover Health Investments, Corp. | 2.77B | -2.41% | 3,552,651 | 2.21B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.75B | -0.04% | 449,486 | 776.83M |
| 223 | MBX | MBX Biosciences, Inc. | 2.70B | 1.61% | 439,943 | - |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.68B | 0.57% | 367,326 | 1.46B |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.65B | 7.46% | 8,438,078 | - |
| 226 | ESTA | Establishment Labs Holdings Inc. | 2.61B | -0.76% | 186,084 | 229.58M |
| 227 | IMNM | Immunome, Inc. | 2.57B | 5.40% | 745,914 | 4.02M |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.52B | 0.97% | 916,341 | - |
| 229 | ASTH | Astrana Health, Inc. | 2.49B | 0.69% | 717,824 | 3.53B |
| 230 | KOD | Kodiak Sciences Inc. | 2.47B | 6.15% | 564,560 | - |
| 231 | NTLA | Intellia Therapeutics, Inc. | 2.43B | 0.96% | 2,756,933 | 66.09M |
| 232 | HTFL | HeartFlow, Inc. | 2.43B | -8.34% | 907,499 | 191.42M |
| 233 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.42B | -1.14% | 1,689,994 | 885.72M |
| 234 | NRIX | Nurix Therapeutics, Inc. | 2.41B | -2.47% | 661,727 | 71.78M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 1.71% | 288,359 | - |
| 236 | BHVN | Biohaven Ltd. | 2.40B | 1.14% | 1,514,115 | - |
| 237 | ABCL | AbCellera Biologics Inc. | 2.40B | 3.29% | 6,075,018 | 79.21M |
| 238 | TMDX | TransMedics Group, Inc. | 2.39B | 1.80% | 533,501 | 635.89M |
| 239 | AXGN | Axogen, Inc. | 2.38B | 1.50% | 989,213 | 238.11M |
| 240 | VCEL | Vericel Corporation | 2.36B | 2.41% | 171,721 | 292.09M |
| 241 | PGNY | Progyny, Inc. | 2.33B | 1.15% | 345,737 | 1.29B |
| 242 | PHVS | Pharvaris N.V. | 2.33B | -1.65% | 305,281 | - |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | 1.76% | 257,152 | 1.09B |
| 244 | LMAT | LeMaitre Vascular, Inc. | 2.31B | 2.47% | 150,749 | 256.28M |
| 245 | XRAY | DENTSPLY SIRONA Inc. | 2.29B | 3.16% | 2,350,677 | 3.68B |
| 246 | NKTR | Nektar Therapeutics | 2.26B | 3.87% | 505,025 | 55.63M |
| 247 | SGRY | Surgery Partners, Inc. | 2.23B | 3.49% | 633,325 | 3.34B |
| 248 | GENB | Generate Biomedicines, Inc. | 2.20B | 3.82% | 356,053 | 30.30M |
| 249 | AGIO | Agios Pharmaceuticals, Inc. | 2.19B | -0.76% | 66,541 | 66.05M |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.14B | 2.07% | 202,044 | 1.93B |
| 251 | ZLAB | Zai Lab Limited | 2.13B | -1.20% | 190,419 | 453.28M |
| 252 | KARD | Kardigan, Inc. | 2.13B | -1.33% | 9,643 | - |
| 253 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | 1.67% | 346,869 | 899.11M |
| 254 | VRDN | Viridian Therapeutics, Inc. | 2.10B | 2.81% | 919,135 | 70.92M |
| 255 | UFPT | UFP Technologies, Inc. | 2.10B | 0.81% | 20,643 | 608.85M |
| 256 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -0.21% | 108,472 | 52.04M |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.06B | 3.88% | 173,133 | - |
| 258 | TSHA | Taysha Gene Therapies, Inc. | 2.06B | -3.16% | 938,830 | 7.47M |
| 259 | ADMA | ADMA Biologics, Inc. | 2.04B | 2.38% | 2,107,969 | 509.86M |
| 260 | PLSE | Pulse Biosciences, Inc. | 2.04B | 4.17% | 86,013 | 751.00K |
| 261 | NEOG | Neogen Corporation | 2.03B | 0.21% | 390,401 | 870.56M |
| 262 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.98% | 78,511 | 32.08M |
| 263 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.02B | 1.06% | 667,051 | -665.00K |
| 264 | HCM | HUTCHMED (China) Limited | 2.01B | 5.57% | 1,899 | 548.51M |
| 265 | WGS | GeneDx Holdings Corp. | 2.01B | -5.59% | 480,126 | 442.68M |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 2.01B | -1.00% | 725,237 | 42.95M |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | 4.51% | 1,967,729 | 2.18B |
| 268 | AVAH | Aveanna Healthcare Holdings Inc. | 1.99B | 3.39% | 1,344,853 | 2.52B |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.99B | 1.82% | 92,536 | 1.20B |
| 270 | RXRX | Recursion Pharmaceuticals, Inc. | 1.99B | 1.91% | 20,828,708 | 66.41M |
| 271 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | -2.72% | 1,181,737 | 298.30M |
| 272 | NEO | NeoGenomics, Inc. | 1.96B | 0.60% | 1,132,374 | 745.97M |
| 273 | NUVB | Nuvation Bio Inc. | 1.96B | 3.87% | 3,240,954 | 143.05M |
| 274 | NVCR | NovoCure Limited | 1.96B | 7.07% | 759,773 | 674.41M |
| 275 | SION | Sionna Therapeutics, Inc. | 1.96B | 4.01% | 35,351 | - |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.95B | 0.10% | 312,741 | 367.34M |
| 277 | BFLY | Butterfly Network, Inc. | 1.95B | -6.05% | 5,375,616 | 102.92M |
| 278 | PGEN | Precigen, Inc. | 1.93B | 3.24% | 2,719,485 | 31.60M |
| 279 | NBTX | Nanobiotix S.A. | 1.92B | -4.26% | 5,155 | 38.27M |
| 280 | ABSI | Absci Corporation | 1.92B | 2.07% | 3,154,266 | 1.84M |
| 281 | OMCL | Omnicell, Inc. | 1.92B | 0.54% | 29,394 | 1.23B |
| 282 | ADUS | Addus HomeCare Corporation | 1.92B | 2.46% | 102,888 | 1.45B |
| 283 | BCAX | Bicara Therapeutics Inc. | 1.91B | 0.42% | 415,658 | - |
| 284 | ZYME | Zymeworks Inc. | 1.88B | - | 237,702 | 81.26M |
| 285 | ANAB | AnaptysBio, Inc. | 1.88B | -1.47% | 33,348 | 232.39M |
| 286 | ATAI | AtaiBeckley Inc. | 1.87B | 4.20% | 7,266,431 | 3.49M |
| 287 | SNDX | Syndax Pharmaceuticals, Inc. | 1.87B | 1.01% | 1,221,492 | 217.17M |
| 288 | RAPP | Rapport Therapeutics, Inc. | 1.87B | -0.96% | 104,303 | 20.00M |
| 289 | MESO | Mesoblast Limited | 1.84B | 0.43% | 103,109 | 65.38M |
| 290 | URGN | UroGen Pharma Ltd. | 1.83B | -0.92% | 365,299 | 140.49M |
| 291 | CMPS | COMPASS Pathways plc | 1.83B | 2.03% | 2,678,586 | - |
| 292 | TRLV | Trulieve Cannabis Corp. | 1.82B | -0.63% | 447,252 | 1.17B |
| 293 | AGL | agilon health, inc. | 1.82B | -2.37% | 103,369 | 5.82B |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.81B | 2.71% | 187,395 | 923.71M |
| 295 | DMRA | Damora Therapeutics, Inc. | 1.80B | 8.16% | 334,009 | - |
| 296 | TYRA | Tyra Biosciences, Inc. | 1.80B | 3.01% | 49,189 | - |
| 297 | ALMR | Alamar Biosciences, Inc. | 1.79B | -1.42% | 21,233 | 87.16M |
| 298 | BHC | Bausch Health Companies Inc. | 1.77B | -0.52% | 915,532 | 10.53B |
| 299 | GHRS | GH Research PLC | 1.77B | -2.42% | 10,416 | - |
| 300 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | -1.26% | 10,993,159 | 285.61M |
| 301 | ZBIO | Zenas BioPharma, Inc. | 1.73B | -1.87% | 779,326 | 10.00M |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.71B | -0.76% | 57,281 | 1.85B |
| 303 | AKTS | Aktis Oncology, Inc. | 1.68B | -1.33% | 214,471 | 8.28M |
| 304 | MAZE | Maze Therapeutics, Inc. | 1.67B | 1.24% | 298,343 | 20.00M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.66B | -0.20% | 402,612 | 2.71B |
| 306 | IMCR | Immunocore Holdings plc | 1.65B | 2.72% | 447,075 | 412.81M |
| 307 | VIR | Vir Biotechnology, Inc. | 1.64B | 1.94% | 501,734 | 65.50M |
| 308 | INVA | Innoviva, Inc. | 1.64B | 1.46% | 48,398 | 420.69M |
| 309 | AAPG | Ascentage Pharma Group International | 1.64B | 0.97% | 2,287 | 82.08M |
| 310 | INNV | InnovAge Holding Corp. | 1.63B | 2.56% | 30,452 | 949.17M |
| 311 | TDOC | Teladoc Health, Inc. | 1.62B | -1.26% | 2,248,320 | 2.51B |
| 312 | MPLT | MapLight Therapeutics, Inc. | 1.61B | -1.52% | 160,089 | - |
| 313 | AVBP | ArriVent BioPharma, Inc. | 1.60B | -0.29% | 30,696 | - |
| 314 | ATRC | AtriCure, Inc. | 1.59B | 5.85% | 771,548 | 552.16M |
| 315 | SVRA | Savara Inc. | 1.58B | 2.64% | 523,137 | - |
| 316 | HROW | Harrow, Inc. | 1.57B | -2.05% | 348,122 | 268.68M |
| 317 | NVAX | Novavax, Inc. | 1.56B | 0.48% | 3,194,264 | 596.34M |
| 318 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | -2.03% | 795,210 | 204.73M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.55B | -1.83% | 713,304 | - |
| 320 | SEPN | Septerna, Inc. | 1.53B | -1.76% | 159,724 | 72.26M |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.52B | -0.76% | 32,996 | 83.72M |
| 322 | ARDT | Ardent Health, Inc. | 1.52B | 4.79% | 316,282 | 6.43B |
| 323 | CDNA | CareDx, Inc. | 1.50B | -0.65% | 445,539 | 412.82M |
| 324 | PRGO | Perrigo Company plc | 1.47B | 3.30% | 1,335,192 | 4.18B |
| 325 | COAG | Hemab Therapeutics Holdings, Inc. | 1.45B | -4.65% | 156,127 | - |
| 326 | AHCO | AdaptHealth Corp. | 1.44B | 1.70% | 217,981 | 3.29B |
| 327 | XERS | Xeris Biopharma Holdings, Inc. | 1.43B | 3.25% | 1,817,136 | 314.85M |
| 328 | PSNL | Personalis, Inc. | 1.43B | -1.31% | 1,971,470 | 64.52M |
| 329 | IART | Integra LifeSciences Holdings Corporation | 1.40B | 0.34% | 180,321 | 1.64B |
| 330 | MNKD | MannKind Corporation | 1.39B | 10.86% | 4,124,498 | 360.78M |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.38B | 1.35% | 1,519,945 | 787.08M |
| 332 | BLFS | BioLife Solutions, Inc. | 1.38B | -0.95% | 294,336 | 101.66M |
| 333 | INBX | Inhibrx Biosciences, Inc. | 1.38B | -1.10% | 124,749 | 1.30M |
| 334 | STAA | STAAR Surgical Company | 1.37B | -1.94% | 199,560 | 290.38M |
| 335 | INSP | Inspire Medical Systems, Inc. | 1.37B | 4.53% | 591,467 | 915.25M |
| 336 | PNTG | The Pennant Group, Inc. | 1.34B | 3.16% | 380,786 | 1.02B |
| 337 | IMTX | Immatics N.V. | 1.34B | -0.71% | 273,010 | 43.00M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.33B | 2.27% | 47,785 | 1.50B |
| 339 | OMDA | Omada Health, Inc. | 1.33B | -1.02% | 531,472 | 283.30M |
| 340 | AMN | AMN Healthcare Services, Inc. | 1.32B | 2.38% | 350,707 | 3.42B |
| 341 | CAPR | Capricor Therapeutics, Inc. | 1.32B | -1.56% | 776,797 | 11.13M |
| 342 | NUTX | Nutex Health Inc. | 1.31B | 0.05% | 154,567 | 879.95M |
| 343 | AVLN | Avalyn Pharma Inc. | 1.29B | -3.66% | 49,050 | - |
| 344 | IRMD | IRADIMED CORPORATION | 1.28B | 2.01% | 69,862 | 86.28M |
| 345 | ARDX | Ardelyx, Inc. | 1.27B | -0.19% | 1,352,841 | 427.68M |
| 346 | ENOV | Enovis Corporation | 1.27B | 10.28% | 383,680 | 2.28B |
| 347 | AHG | Akso Health Group | 1.27B | -1.99% | 1,807 | 14.84M |
| 348 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 1.69% | 614,358 | - |
| 349 | SDGR | Schrödinger, Inc. | 1.24B | 1.19% | 751,376 | 254.91M |
| 350 | JBIO | Jade Biosciences, Inc. | 1.23B | -4.61% | 729,920 | - |
| 351 | MGTX | MeiraGTx Holdings plc | 1.23B | 4.06% | 378,266 | 79.76M |
| 352 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -8.61% | 1,003,565 | 322.02M |
| 353 | QDEL | QuidelOrtho Corporation | 1.22B | -1.71% | 427,814 | 2.66B |
| 354 | ALVO | Alvotech | 1.21B | -0.42% | 39,010 | 562.04M |
| 355 | COLL | Collegium Pharmaceutical, Inc. | 1.20B | 3.07% | 181,891 | 796.33M |
| 356 | AZTA | Azenta, Inc. | 1.20B | -0.80% | 188,627 | 596.48M |
| 357 | LMRI | Lumexa Imaging Holdings, Inc. | 1.19B | 6.99% | 944,850 | 1.03B |
| 358 | WVE | Wave Life Sciences Ltd. | 1.19B | 5.65% | 2,519,798 | 71.80M |
| 359 | EYPT | EyePoint, Inc. | 1.18B | 6.25% | 739,211 | 7.61M |
| 360 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | 3.95% | 726,492 | - |
| 361 | AVNS | Avanos Medical, Inc. | 1.17B | 1.20% | 56,802 | 715.90M |
| 362 | DRTS | Alpha Tau Medical Ltd. | 1.16B | 1.94% | 658,635 | - |
| 363 | OPK | OPKO Health, Inc. | 1.15B | -0.65% | 1,265,704 | 581.12M |
| 364 | AORT | Artivion, Inc. | 1.15B | 0.25% | 79,426 | 458.69M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.13B | -1.49% | 49,935 | - |
| 366 | SANA | Sana Biotechnology, Inc. | 1.11B | 3.65% | 2,773,138 | - |
| 367 | USPH | U.S. Physical Therapy, Inc. | 1.10B | 1.44% | 242,727 | 787.69M |
| 368 | VOR | Vor Biopharma Inc. | 1.09B | 9.87% | 2,958,127 | - |
| 369 | XNCR | Xencor, Inc. | 1.09B | -4.00% | 371,857 | 97.36M |
| 370 | BIOA | BioAge Labs, Inc. | 1.09B | 0.95% | 163,006 | 10.32M |
| 371 | OLMA | Olema Pharmaceuticals, Inc. | 1.09B | 2.98% | 532,565 | - |
| 372 | CERT | Certara, Inc. | 1.08B | 3.34% | 1,975,042 | 419.75M |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | 1.04% | 591,990 | - |
| 374 | TNDM | Tandem Diabetes Care, Inc. | 1.07B | -1.08% | 790,907 | 1.03B |
| 375 | EVO | Evotec SE | 1.05B | 0.70% | 18,948 | 859.03M |
| 376 | SLDB | Solid Biosciences Inc. | 1.04B | 3.63% | 1,056,548 | - |
| 377 | CRON | Cronos Group Inc. | 1.03B | -0.35% | 625,839 | 159.54M |
| 378 | CNMD | CONMED Corporation | 1.02B | 3.72% | 160,063 | 1.37B |
| 379 | ETON | Eton Pharmaceuticals, Inc. | 1.02B | 1.53% | 216,698 | 86.93M |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.01B | -2.99% | 1,683,810 | 69.64M |
| 381 | GDRX | GoodRx Holdings, Inc. | 1.00B | -3.10% | 545,784 | 787.89M |
| 382 | PCRX | Pacira BioSciences, Inc. | 993.14M | 0.84% | 35,844 | 734.86M |
| 383 | AVR | Anteris Technologies Global Corp. | 975.37M | 0.80% | 496,552 | 1.85M |
| 384 | PHAR | Pharming Group N.V. | 964.46M | 0.47% | 2,723 | 369.49M |
| 385 | KURA | Kura Oncology, Inc. | 958.76M | 0.19% | 797,819 | 71.64M |
| 386 | ABUS | Arbutus Biopharma Corporation | 946.21M | 1.27% | 1,152,401 | 191.45M |
| 387 | DBVT | DBV Technologies S.A. | 943.69M | -0.32% | 111,127 | 5.74M |
| 388 | LBRX | LB Pharmaceuticals Inc | 942.89M | 3.10% | 189,527 | - |
| 389 | JANX | Janux Therapeutics, Inc. | 940.99M | 5.25% | 458,201 | 13.73M |
| 390 | INMD | InMode Ltd. | 935.18M | 0.54% | 419,733 | 374.64M |
| 391 | REPL | Replimune Group, Inc. | 935.15M | -0.71% | 1,612,662 | - |
| 392 | AVTX | Avalo Therapeutics, Inc. | 910.96M | 0.23% | 757,247 | 59.00K |
| 393 | SLBT | SL Science Holding Limited | 898.64M | 24.94% | 355,467 | - |
| 394 | DSGN | Design Therapeutics, Inc. | 894.38M | -2.32% | 448,736 | - |
| 395 | PHAT | Phathom Pharmaceuticals, Inc. | 886.44M | 5.93% | 410,088 | 204.89M |
| 396 | IVA | Inventiva S.A. | 885.58M | 5.83% | 1,164,152 | 7.94M |
| 397 | TBPH | Theravance Biopharma, Inc. | 874.85M | -0.06% | 784,801 | 109.78M |
| 398 | ANRO | Alto Neuroscience, Inc. | 870.33M | -0.56% | 231,299 | - |
| 399 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 1,889,330 | 238.37M |
| 400 | ANNX | Annexon, Inc. | 869.18M | -4.41% | 1,230,087 | - |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 867.31M | -2.14% | 30,206 | 720.53M |
| 402 | BVS | Bioventus Inc. | 855.40M | 3.96% | 369,658 | 576.30M |
| 403 | OCS | Oculis Holding AG | 849.66M | 3.99% | 38,236 | 1.40M |
| 404 | GERN | Geron Corporation | 837.18M | 2.76% | 6,073,716 | 196.12M |
| 405 | AURA | Aura Biosciences, Inc. | 836.62M | 12.70% | 618,779 | - |
| 406 | HSTM | HealthStream, Inc. | 833.51M | 0.88% | 68,009 | 311.78M |
| 407 | ESPR | Esperion Therapeutics, Inc. | 814.77M | 0.16% | 5,283,803 | 418.24M |
| 408 | ODTX | Odyssey Therapeutics, Inc. | 814.40M | 2.41% | 77,311 | 1.06M |
| 409 | CTMX | CytomX Therapeutics, Inc. | 809.85M | 3.33% | 2,410,576 | 35.54M |
| 410 | ZVRA | Zevra Therapeutics, Inc. | 808.10M | -1.01% | 503,392 | 122.29M |
| 411 | SPRY | ARS Pharmaceuticals, Inc. | 800.38M | 1.51% | 927,661 | 98.99M |
| 412 | GMRS | GMR Solutions Inc. | 797.75M | 0.07% | 283,631 | 5.83B |
| 413 | ACRS | Aclaris Therapeutics, Inc. | 758.37M | 1.69% | 833,452 | 8.37M |
| 414 | SIBN | SI-BONE, Inc. | 755.05M | 1.34% | 38,574 | 206.22M |
| 415 | CBLL | CeriBell, Inc. | 750.13M | -1.15% | 601,834 | 95.07M |
| 416 | TENX | Tenax Therapeutics, Inc. | 746.45M | 9.93% | 2,915,844 | - |
| 417 | SSII | SS Innovations International, Inc. | 742.49M | -5.84% | 5,651 | 48.47M |
| 418 | CSTL | Castle Biosciences, Inc. | 737.62M | -1.58% | 18,649 | 339.92M |
| 419 | BBNX | Beta Bionics, Inc. | 728.81M | -2.07% | 358,840 | 110.24M |
| 420 | CLYM | Climb Bio, Inc. | 718.05M | -5.64% | 545,990 | - |
| 421 | CADL | Candel Therapeutics, Inc. | 712.92M | -1.52% | 893,515 | - |
| 422 | RIGL | Rigel Pharmaceuticals, Inc. | 708.26M | -0.03% | 197,645 | 299.77M |
| 423 | ALLO | Allogene Therapeutics, Inc. | 705.84M | -3.08% | 5,480,688 | 22.00K |
| 424 | DRUG | Bright Minds Biosciences Inc. | 704.76M | 0.71% | 137,250 | - |
| 425 | IMMX | Immix Biopharma, Inc. | 701.93M | 0.31% | 826,167 | - |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 697.96M | 2.91% | 1,327,381 | 361.51M |
| 427 | RGNX | REGENXBIO Inc. | 694.04M | 2.56% | 2,351,268 | 87.82M |
| 428 | PRME | Prime Medicine, Inc. | 691.76M | -1.54% | 4,294,595 | 4.03M |
| 429 | TCMD | Tactile Systems Technology, Inc. | 688.87M | -0.36% | 233,866 | 343.52M |
| 430 | CRMD | CorMedix Inc. | 682.53M | 2.72% | 584,744 | 400.05M |
| 431 | TECX | Tectonic Therapeutic, Inc. | 682.12M | 10.42% | 243,800 | - |
| 432 | PHR | Phreesia, Inc. | 681.17M | 2.80% | 399,312 | 495.59M |
| 433 | RLMD | Relmada Therapeutics, Inc. | 667.10M | -0.47% | 670,765 | - |
| 434 | FDMT | 4D Molecular Therapeutics, Inc. | 665.74M | 0.35% | 446,623 | 88.24M |
| 435 | DNA | Ginkgo Bioworks Holdings, Inc. | 663.37M | -1.22% | 537,846 | 151.40M |
| 436 | ACHV | Achieve Life Sciences, Inc. | 658.56M | 0.23% | 818,777 | - |
| 437 | EIKN | Eikon Therapeutics, Inc. | 658.33M | -0.73% | 212,901 | - |
| 438 | OMER | Omeros Corporation | 657.17M | -3.51% | 683,502 | 9.89M |
| 439 | MNPR | Monopar Therapeutics Inc. | 649.78M | 2.07% | 111,138 | - |
| 440 | TRAX | First Tracks Biotherapeutics, Inc. | 643.76M | -0.75% | 292,159 | - |
| 441 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 643.26M | 2.95% | 54,147 | - |
| 442 | SGP | SpyGlass Pharma, Inc. | 639.91M | -1.69% | 61,729 | - |
| 443 | GYRE | Gyre Therapeutics, Inc. | 631.38M | 5.98% | 3,749 | 117.05M |
| 444 | BWAY | BrainsWay Ltd. | 626.08M | -0.39% | 48,687 | 56.22M |
| 445 | EVH | Evolent Health, Inc. | 623.15M | -3.48% | 1,647,900 | 1.89B |
| 446 | AGMB | AgomAb Therapeutics NV | 622.49M | 6.49% | 5,879 | - |
| 447 | CERS | Cerus Corporation | 622.15M | 3.50% | 2,358,999 | 216.56M |
| 448 | ALT | Altimmune, Inc. | 616.48M | 0.63% | 2,084,918 | 36.00K |
| 449 | PROK | ProKidney Corp. | 596.57M | 4.50% | 1,142,864 | 889.00K |
| 450 | CTKB | Cytek Biosciences, Inc. | 590.83M | -0.11% | 375,637 | 204.17M |
| 451 | MDXG | MiMedx Group, Inc. | 583.87M | 0.51% | 295,663 | 389.42M |
| 452 | FLGT | Fulgent Genetics, Inc. | 583.35M | -1.34% | 75,663 | 320.35M |
| 453 | NNNN | Anbio Biotechnology | 572.78M | 5.71% | 7,231 | 8.65M |
| 454 | FTH | Faeth Therapeutics, Inc. | 566.23M | -7.16% | 131,839 | - |
| 455 | MYGN | Myriad Genetics, Inc. | 565.74M | -0.17% | 475,417 | 829.00M |
| 456 | CBIO | Crescent Biopharma, Inc. | 560.57M | -1.23% | 164,592 | 11.88M |
| 457 | TLRY | Tilray Brands, Inc. | 552.28M | 4.51% | 4,294,039 | 858.28M |
| 458 | CTNM | Contineum Therapeutics, Inc. | 550.70M | -3.35% | 36,241 | - |
| 459 | CTEV | Claritev Corporation | 550.13M | -0.40% | 8,615 | 978.76M |
| 460 | ANGO | AngioDynamics, Inc. | 545.83M | 0.11% | 163,619 | 313.73M |
| 461 | NPCE | NeuroPace, Inc. | 545.50M | 1.46% | 43,598 | 99.53M |
| 462 | CLPT | ClearPoint Neuro, Inc. | 542.21M | -3.42% | 363,564 | 40.61M |
| 463 | ARVN | Arvinas, Inc. | 540.04M | 2.07% | 313,826 | 89.40M |
| 464 | KYTX | Kyverna Therapeutics, Inc. | 536.82M | 4.62% | 897,620 | - |
| 465 | EDIT | Editas Medicine, Inc. | 535.58M | 6.40% | 2,938,050 | 38.69M |
| 466 | XOMA | XOMA Royalty Corporation | 534.12M | -0.07% | 6,686 | 48.56M |
| 467 | NGNE | Neurogene Inc. | 531.73M | -0.68% | 124,105 | 925.00K |
| 468 | FBRX | Forte Biosciences, Inc. | 531.48M | 2.02% | 149,223 | - |
| 469 | ASMB | Assembly Biosciences, Inc. | 528.33M | -0.11% | 126,720 | 71.10M |
| 470 | TOI | The Oncology Institute, Inc. | 525.91M | -4.54% | 698,380 | 545.76M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 522.50M | -1.77% | 1,205,097 | 50.27M |
| 472 | PACB | Pacific Biosciences of California, Inc. | 521.81M | -3.45% | 3,470,608 | 160.03M |
| 473 | WEAV | Weave Communications, Inc. | 518.77M | 1.72% | 560,484 | 248.72M |
| 474 | NVCT | Nuvectis Pharma, Inc. | 518.57M | 0.15% | 59,187 | - |
| 475 | STTK | Shattuck Labs, Inc. | 515.29M | 3.23% | 84,083 | 1.00M |
| 476 | RZLT | Rezolute, Inc. | 511.89M | -1.01% | 595,241 | - |
| 477 | KIDS | OrthoPediatrics Corp. | 511.00M | 3.08% | 67,993 | 243.30M |
| 478 | CABA | Cabaletta Bio, Inc. | 509.55M | 4.52% | 6,591,401 | - |
| 479 | OCGN | Ocugen, Inc. | 509.48M | 1.69% | 4,349,013 | 4.47M |
| 480 | PRTA | Prothena Corporation plc | 509.40M | 1.57% | 35,196 | 57.94M |
| 481 | CYH | Community Health Systems, Inc. | 509.30M | 6.21% | 2,740,221 | 12.29B |
| 482 | NRC | NRC Health | 504.60M | 0.22% | 25,527 | 138.64M |
| 483 | STRO | Sutro Biopharma, Inc. | 504.40M | 0.66% | 36,191 | 99.61M |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 485 | OVID | Ovid Therapeutics Inc. | 494.60M | -1.12% | 1,045,816 | 7.12M |
| 486 | SLN | Silence Therapeutics plc | 492.65M | -0.67% | 233,256 | 839.00K |
| 487 | VALN | Valneva SE | 487.25M | 1.38% | 1,743 | 180.25M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 482.99M | -0.81% | 188,461 | 16.72M |
| 489 | ZURA | Zura Bio Limited | 471.19M | -0.90% | 517,441 | - |
| 490 | EVMN | Evommune, Inc. | 468.96M | 1.56% | 751,710 | 10.00M |
| 491 | CCCC | C4 Therapeutics, Inc. | 464.38M | -3.23% | 1,541,290 | 34.86M |
| 492 | SGMT | Sagimet Biosciences Inc. | 460.05M | -0.13% | 350,942 | - |
| 493 | SOPH | SOPHiA GENETICS SA | 458.91M | -2.15% | 232,495 | 81.18M |
| 494 | SRTA | Strata Critical Medical, Inc. | 454.26M | -0.57% | 613,242 | 228.58M |
| 495 | VMD | Viemed Healthcare, Inc. | 451.03M | 0.21% | 176,910 | 286.57M |
| 496 | ARTV | Artiva Biotherapeutics, Inc. | 450.41M | -5.41% | 271,586 | 251.00K |
| 497 | DCTH | Delcath Systems, Inc. | 450.16M | 1.01% | 168,907 | 90.44M |
| 498 | VREX | Varex Imaging Corporation | 447.60M | -0.56% | 167,321 | 857.50M |
| 499 | MOBI | Mobia Medical, Inc. | 445.87M | 1.90% | 22,173 | 38.45M |
| 500 | EOLS | Evolus, Inc. | 443.20M | -0.15% | 224,440 | 301.79M |